PBT didn't fail human trials.. It was pulled during production because of toxicity issues in manufacturing process.. It was replaced by pbt2 at same time as it was already there and did what pbt did but better
PBT2 primary target is Alzheimer's.. Always has been . But going for HD is potentially faster and cheaper route for prana and has been their plan for a number of years now.
HD gets the party started .. Then there are those on AD who may consider using the drug off label anyway while prana continues to progress it through clinical trials
Pbt434 starting in clinic soon also ( submission in according to annual report )
For someone who claims to be in the industry you don't seem to deal with truth very well
Research finds that ultrasound slows brain ageing, page-65
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $1.247K | 384.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 52935756 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 127950526 | 19 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| ATH (ASX) Chart |